All consulting services
01
Therapeutic discovery and development
Independent scientific assessment of a therapeutic concept, from mechanism to development plan, with particular depth in cardiovascular disease and relevance to oncology and respiratory medicine.

Typical questions
- Is the target rationale supported by human genetic and translational evidence?
- Which preclinical and early clinical data would make the programme credible to regulators, partners and investors?
- How should a cardiovascular, oncology or respiratory candidate be positioned against the standard of care and emerging classes?
- Where are the scientific risks, and what would reduce them?
What you receive
- 1A written scientific assessment with cited evidence
- 2A prioritised list of experiments and studies with rationale
- 3Advisory sessions with the professor, minuted
Well suited to
Biotech and pharmaceutical teams, academic spin-outs and investors seeking scientific due diligence.